Douglas Yee
Affiliations: | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Douglas Yee"Children
Sign in to add trainee| Jennifer M. Gross | grad student | 2004 | UMN |
| Sara A. Byron | grad student | 2005 | UMN |
| Xianke Zeng | grad student | 2009 | UMN |
| Marc A. Becker | grad student | 2010 | UMN |
| Dedra H. Fagan | grad student | 2012 | UMN |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Magbanua MJM, Ahmed Z, Sayaman RW, et al. (2024) Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Kyalwazi B, Yau C, Campbell MJ, et al. (2023) Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. Jama Network Open. 6: e2349646 |
| Albain KS, Yau C, Petricoin EF, et al. (2023) Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gallagher RI, Wulfkuhle J, Wolf DM, et al. (2023) Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell Reports. Medicine. 101312 |
| Monteiro M, Zhang X, Yee D. (2023) Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells. Experimental Cell Research. 434: 113862 |
| Rajoria B, Zhang X, Yee D. (2023) IGF-1 Stimulates Glycolytic ATP Production in MCF-7L Cells. International Journal of Molecular Sciences. 24 |
| Tarullo SE, He Y, Daughters C, et al. (2023) Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology |
| Magbanua MJM, Brown Swigart L, Ahmed Z, et al. (2023) Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Cancer Cell |
| Zhang X, Varma S, Yee D. (2023) Suppression of Insulin Receptor Substrate 1 Inhibits Breast Cancer Growth In Vitro and in Female Athymic Mice. Endocrinology. 164 |
| Lang JE, Forero-Torres A, Yee D, et al. (2022) Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. Npj Breast Cancer. 8: 128 |